|
1
|
Sharif A, Kheirkhah D, Sharif MR, Karimian
M and Karimian Z: ABCB1-C3435T polymorphism and breast cancer risk:
A case-control study and a meta-analysis. J BUON. 21:1433–1441.
2016.PubMed/NCBI
|
|
2
|
Zaib S, Tahir S, Masood N, Hameed A and
Azra Y: A meta-analysis and experimental data for multidrug
resistance genes in breast cancer. Afr Health Sci. 22:1–9. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Macias-Gomez NM, Gutiérrez-Angulo M,
Leal-Ugarte E, Ramírez-Reyes L, Peregrina-Sandoval J, Meza-Espinoza
JP, Solano FR, de la Luz Ayala-Madrigal M and Telles FS: MDR1
C3435T polymorphism in Mexican patients with breast cancer. Genet
Mol Res. 13:5018–5024. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sheng X, Zhang L, Tong N, Luo D, Wang M,
Xu M and Zhang Z: MDR1 C3435T polymorphism and cancer risk: A
meta-analysis based on 39 case-control studies. Mol Biol Rep.
39:7237–7249. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Turgut S, Turgut G and Atalay EO: Genotype
and allele frequency of human multidrug resistance (MDR1) gene
C3435T polymorphism in Denizli province of Turkey. Mol Biol Rep.
33:295–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Wang B, Bi J, Li K and Di J: MDR1
gene C3435T polymorphism and cancer risk: A meta-analysis of 34
case-control studies. J Cancer Res Clin Oncol. 138:979–989. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cizmarikova M, Wagnerova M, Schonova L,
Habalova V, Kohut A, Linkova A, Sarissky M, Mojzis J, Mirossay L
and Mirossay A: MDR1 (C3435T) polymorphism: Relation to the risk of
breast cancer and therapeutic outcome. Pharmacogenomics J.
10:62–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gutierrez-Rubio SA, Quintero-Ramos A,
Durán-Cárdenas A, Franco-Topete RA, Castro-Cervantes JM,
Oceguera-Villanueva A, Jiménez-Pérez LM, Balderas-Peña LM,
Morgan-Villela G, Del-Toro-Arreola A and Daneri-Navarro A: 1236 C/T
and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast
cancer patients. Genet Mol Res. 14:1250–1259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abuhaliema AM, Yousef AM, Elmadany NN,
Bulatova NR, Awwad NM, Yousef MA and Al Majdalawi KZ: Influence of
Genotype and Haplotype of MDR1 (C3435T, G2677A/T, C1236T) on the
incidence of breast cancer-a case-control study in Jordan. Asian
Pac J Cancer Prev. 17:261–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jaramillo-Rangel G, Ortega-Martínez M,
Cerda-Flores RM and Barrera-Saldaña HA: C3435T polymorphism in the
MDR1 gene and breast cancer risk in northeastern Mexico. Int J Clin
Exp Pathol. 11:904–909. 2018.PubMed/NCBI
|
|
11
|
Tatari F, Salek R, Mosaffa F, Khedri A and
Behravan J: Association of C3435T single-nucleotide polymorphism of
MDR1 gene with breast cancer in an Iranian population. DNA Cell
Biol. 28:259–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Henríquez-Hernández LA, Murias-Rosales A,
González AH, Cabrera De León A, Díaz-Chico BN, De Santiago MM and
Pérez LF: Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk
factors for breast cancer: A case-control study. Oncol Rep.
22:1425–1433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghafouri H, Ghaderi B, Amin S, Nikkhoo B,
Abdi M and Hoseini A: Association of ABCB1 and ABCG2 single
nucleotide polymorphisms with clinical findings and response to
chemotherapy treatments in Kurdish patients with breast cancer.
Tumour Biol. 37:7901–7906. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tazzite A, Kassogue Y, Diakité B, Jouhadi
H, Dehbi H, Benider A and Nadifi S: Association between ABCB1
C3435T polymorphism and breast cancer risk: A Moroccan case-control
study and meta-analysis. BMC Genet. 17:1262016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Zhang D, Du F, Xing X, Wu Y, Xiao D,
Liang M, Fan Z, Zhao P, Liu T and Li G: ABCB1 3435TT and ABCG2
421CC genotypes were significantly associated with longer
progression-free survival in Chinese breast cancer patients.
Oncotarget. 8:111041–111052. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Al-Eitan LN, Rababa'h DM, Alghamdi MA and
Khasawneh RH: Role of four ABC transporter genes in pharmacogenetic
susceptibility to breast cancer in Jordanian patients. J Oncol.
2019:1–8. 2019. View Article : Google Scholar
|
|
17
|
Rubiś B, Hołysz H, Barczak W, Gryczka R,
Łaciński M, Jagielski P, Czernikiewicz A, Półrolniczak A, Wojewoda
A, Perz K, et al: Study of ABCB1 polymorphism frequency in breast
cancer patients from Poland. Pharmacol Rep. 64:1560–1566. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Higgins JPT and Green SE: Cochrane
Handbook for Systematic Reviews of Interventions version 5.1.0
[updated March 2011]. London, UK: The Cochrane Collaboration; 2011,
Available from:. www.cochrane-handbook.org
|
|
19
|
MARIE-GENICA Consortium on Genetic
Susceptibility for Menopausal Hormone Therapy Related Breast Cancer
Risk, . Polymorphisms in the BRCA1 and ABCB1 genes modulate
menopausal hormone therapy associated breast cancer risk in
postmenopausal women. Breast Cancer Res Treat. 120:727–736. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kioka N, Tsubota J, Kakehi Y, Komano T,
Gottesman MM, Pastan I and Ueda K: P-glycoprotein gene (MDR1) cDNA
from human adrenal: Normal P-glycoprotein carries Gly185 with an
altered pattern of multidrug resistance. Biochem Biophys Res
Commun. 162:224–231. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marzolini C, Paus E, Buclin T and Kim RB:
Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and
clinical relevance. Clin Pharmacol Ther. 75:13–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Wang T and Bian J: Association
between MDR1 C3435T polymorphism and risk of breast cancer. Gene.
532:94–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taheri M, Mahjoubi F and Omranipour R:
Effect of MDR1 polymorphism on multidrug resistance expression in
breast cancer patients. Genet Mol Res. 9:34–40. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Totoń E, Jacczak B, Barczak W, Jagielski
P, Gryczka R, Hołysz H, Grodecka-Gazdecka S and Rubiś B: No
association between ABCB1 G2677T/A or C3435T polymorphisms and
survival of breast cancer patients-a 10-year follow-up study in the
Polish population. Genes. 13:7292022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nordgard SH, Ritchie MD, Jensrud SD,
Motsinger AA, Alnaes GI, Lemmon G, Berg M, Geisler S, Moore JH,
Lønning PE, et al: ABCB1 and GST polymorphisms associated with TP53
status in breast cancer. Pharmacogenet Genomics. 17:127–136. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
George J, Dharanipragada K, Krishnamachari
S, Chandrasekaran A, Sam SS and Sunder E: A single-nucleotide
polymorphism in the MDR1 gene as a predictor of response to
neoadjuvant chemotherapy in breast cancer. Clin Breast Cancer.
9:161–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu PH, Wei MX, Yang J, Liu X, Tao GQ, Shen
W and Chen MB: Association between two polymorphisms of ABCB1 and
breast cancer risk in the current studies: A meta-analysis. Breast
Cancer Res Treat. 125:537–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ozdemir S, Uludag A, Silan F, Atik SY,
Turgut B and Ozdemir O: Possible roles of the Xenobiotic
transporter P-glycoproteins encoded by the MDR1 3435 C>T gene
polymorphism in differentiated thyroid cancers. Asian Pac J Cancer
Prev. 14:3213–3217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu H, Kang H, Liu Y, Tong W, Liu D, Yang
X, Lian M, Yao W, Zhao H, Huang D, et al: Roles of ABCB1 gene
polymorphisms and haplotype in susceptibility to breast carcinoma
risk and clinical outcomes. J Cancer Res Clin Oncol. 138:1449–1162.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Turgut S, Yaren A, Kursunluoglu R and
Turgut G: MDR1 C3435T polymorphism in patients with breast cancer.
Arch Med Res. 38:539–544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fawzy MS, Awad HA, Ahmad HS, Kamel LM and
Tom MM: Multi-drug resistance 1 genetic polymorphisms gene
expression and prediction of chemotherapy response in breast cancer
Egyptian patients. Egypt J Biochem Mol Biol. 32:75–98. 2014.
|
|
32
|
MARIE-GENICA Consortium on Genetic
Susceptibility for Menopausal Hormone Therapy Related Breast Cancer
Risk, . Polymorphisms in the BRCA1 and ABCB1 genes modulate
menopausal hormone therapy associated breast cancer risk in
postmenopausal women. Breast Cancer Res Treat. 120:727–736. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zeliha KP, Dilek O, Ezgi O, Halil K, Cihan
U and Gul O: Association between ABCB1, ABCG2 carrier protein and
COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish
population. Saudi Pharm J. 28:215–219. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang L, Song YB, Zheng WL, Jiang L and Ma
WL: The association between polymorphisms in the MDR1 gene and risk
of cancer: A systematic review and pooled analysis of 52
case-control studies. Cancer Cell Int. 13:462013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang Y, Zhao Q, Ma G, Han Y and Lou N:
Investigation on MDR1 gene polymorphisms and its relationship with
breast cancer risk factors in Chinese women. Med Oncol. 30:3752013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zubor P, Lasabova Z, Hatok J, Stanclova A
and Danko J: A polymorphism C3435T of the MDR-1 gene associated
with smoking or high body mass index increases the risk of sporadic
breast cancer in women. Oncol Rep. 18:211–217. 2007.PubMed/NCBI
|
|
37
|
Sauer G, Kafka A, Grundmann R, Kreienberg
R, Zeillinger R and Deissler H: Basal expression of the multidrug
resistance gene 1 (MDR-1) is associated with the TT genotype at the
polymorphic site C3435T in mammary and ovarian carcinoma cell
lines. Cancer Lett. 185:79–85. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rodrigues FF, Santos RE, Melo MB, Silva
MA, Oliveira AL, Rozenowicz RL, Ulson LB and Aoki T: Correlation of
polymorphism C3435T of the MDR-1 gene and the response of primary
chemotherapy in women with locally advanced breast cancer. Genet
Mol Res. 7:177–183. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vaclavikova R, Ehrlichova M, Hlavata I,
Pecha V, Kozevnikovova R, Trnkova M, Adamek J, Edvardsen H,
Kristensen VN, Gut I and Soucek P: Detection of frequent ABCB1
polymorphisms by high-resolution melting curve analysis and their
effect on breast carcinoma prognosis. Clin Chem Lab Med.
50:1999–2007. 2012. View Article : Google Scholar : PubMed/NCBI
|
